Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Search

Total 158 results found. Search for [ Mylan ]

Results 1 to 21 of 158
PTI
March 22, 2019



BusinessToday.In
February 18, 2019
The Glenmark Pharmaceuticals share price surged up to 3.89% to 591.80 compared to the previous close of 569.65 in trade today.


PTI
February 18, 2019



E Kumar Sharma
New Delhi, February 14, 2019
Despite no big product launches in the US last year, Natco Pharma gained from its strategy of focussing on a few big products. It now hopes to build on this.


E Kumar Sharma
January 25, 2019
Biocon reports robust growth across all business segments: Biologics, small molecules, branded formulations and research services


E Kumar Sharma
January 18, 2019
Globally, the number of diabetes patients is at around half a billion with over 30 million in the US alone, the most sought after market for diabetes care companies, especially those into insulin.


PB Jayakumar
New Delhi, January 9, 2019
Ogivri is the biosimilar version of Swiss drug maker Roches Herceptin, a breast cancer and gastric cancer drug with sales of $6.9 billion a year worldwide


PB Jayakumar
December 19, 2018
Ogivri (Trastuzumab), jointly developed by Biocon and Mylan, is the biosimilar version of Swiss drug maker Roche's Herceptin.


PTI
December 19, 2018



PTI
December 19, 2018



PTI
December 14, 2018



PTI
December 14, 2018



BusinessToday.In
December 12, 2018
The stock fell 5.16% intra day to 2569 level on the BSE. The large cap stock has fallen after two days of consecutive gain. On NSE, the stock fell 5.45% to 2,568 level. The stock was the top loser on Nifty.


PTI
November 30, 2018



PTI
November 30, 2018



PTI
November 26, 2018



PB Jayakumar
New Delhi, November 26, 2018
Market changes and increased regulatory oversight in the US have hurt Lupin, but India's third-biggest drug maker is making efforts to come back.


E Kumar Sharma
New Delhi, November 26, 2018
Teva, Mylan, and even India's biggest, Sun Pharma, are opting out of products that aren't commercially viable.


E Kumar Sharma
New Delhi, November 21, 2018
Some of the leading Indian pharma companies are pitching in to cater to the markets that some of the big pharma companies are vacating as part of their product optimisation strategies.


BusinessToday.In
November 21, 2018
Suboxone is British drugmaker Indivior's best-selling opioid addiction treatment drug in the US. Shares of Indivior tanked about 47 percent on Tuesday, in a record single-day fall. Jefferies analysts said they consider the ruling to be near-term positive, and one that allows the company to immediately re-launch the product, but still at-risk.


PAGES 1 OF 8  12345